PFE (STOCKS)
Pfizer Inc.
$25.250000
-0.670000 (-2.58%)
Prev close: $25.920000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Albert Bourla
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $143,739.97M
- Employees
- 81,000
- P/E (TTM)
- 19.87
- P/B (TTM)
- 1.64
- Dividend Yield
- 663.58%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
9
Buy
18
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.75 | $0.72 | +0.0257 | +3.55% |
|
Dec 2025 (Q4)
|
$0.66 | $0.58 | +0.0825 | +14.29% |
|
Sep 2025 (Q3)
|
$0.87 | $0.64 | +0.2303 | +36.00% |
|
Jun 2025 (Q2)
|
$0.78 | $0.59 | +0.1931 | +32.90% |
Financial Statements
| Revenues | $63.32B |
| Benefits Costs and Expenses | $55.41B |
| Cost Of Revenue | $16.77B |
| Costs And Expenses | $55.41B |
| Gross Profit | $46.55B |
| Operating Expenses | $38.64B |
| Selling, General, and Administrative Expenses | $13.72B |
| Other Operating Expenses | $24.92B |
| Operating Income/Loss | $7.91B |
| Income/Loss From Continuing Operations After Tax | $7.52B |
| Income/Loss From Continuing Operations Before Tax | $7.91B |
| Income/Loss From Discontinued Operations Net Of Tax | $12.00M |
| Income Tax Expense/Benefit | $384.00M |
| Income Tax Expense/Benefit, Deferred | -$1.48B |
| Interest Expense, Operating | $2.69B |
| Net Income/Loss | $7.53B |
| Net Income/Loss Attributable To Noncontrolling Interest | $43.00M |
| Net Income/Loss Attributable To Parent | $7.49B |
| Net Income/Loss Available To Common Stockholders, Basic | $7.49B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.31 |
| Diluted Earnings Per Share | $1.31 |
| Basic Average Shares | 17,062,000,000 |
| Diluted Average Shares | 17,154,000,000 |
| Assets | $207.62B |
| Current Assets | $42.82B |
| Inventory | $10.67B |
| Other Current Assets | $32.16B |
| Noncurrent Assets | $164.80B |
| Fixed Assets | $19.40B |
| Intangible Assets | $52.56B |
| Other Non-current Assets | $92.84B |
| Liabilities | $117.21B |
| Current Liabilities | $34.35B |
| Accounts Payable | $4.51B |
| Wages | $2.72B |
| Other Current Liabilities | $27.13B |
| Noncurrent Liabilities | $82.87B |
| Equity | $90.40B |
| Equity Attributable To Noncontrolling Interest | $303.00M |
| Equity Attributable To Parent | $90.10B |
| Liabilities And Equity | $207.62B |
| Net Cash Flow From Operating Activities | $11.98B |
| Net Cash Flow From Operating Activities, Continuing | $11.98B |
| Net Cash Flow From Investing Activities | -$3.84B |
| Net Cash Flow From Investing Activities, Continuing | -$3.84B |
| Net Cash Flow From Financing Activities | -$7.93B |
| Net Cash Flow From Financing Activities, Continuing | -$7.93B |
| Exchange Gains/Losses | $67.00M |
| Net Cash Flow | $278.00M |
| Net Cash Flow, Continuing | $211.00M |
| Comprehensive Income/Loss | $8.90B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $30.00M |
| Comprehensive Income/Loss Attributable To Parent | $8.87B |
| Other Comprehensive Income/Loss | $1.37B |